Posts Tagged ‘treatment’
Saturday, November 15th, 2008
The immature labeling is based on clinical deliberate over data. The most late study, involving 86 children with ADHD between the ages of six and 12, showed that Focalin Xr provided significant improvements at 30 minutes post-dose compared to placebo in measures of attention, deportment, and erudite productivity. ADHD affects approximately three to six percent of children in the United States, and its symptoms - inattention, hyperactivity and impulsivity - can significantly bearing a child's cleverness to pinpoint and bear in school.
A 2007 Harris size up of 1,001 caregivers of babyish ADHD patients revealed that caregivers were significantly more qualified to reveal that their child's or adolescent's behavior was negatively counterfeit in the matutinal compared to Other periods through the age in 12 out of 16 undistinguished behaviors. These cold behaviors included fall short of of concentration, messiness, interrupting others, flop to full tasks and speaking out of turn. "The 30-minute attack of effect can aide children with ADHD modernize their matinal lettered productivity in school. Focalin Xr also allows them to effectively shift their symptoms for up to 12 hours getting them through college and homework time," said Rafael Muniz, MD, Senior Medical Director, Novartis Pharmaceuticals Corporation.
(more...)
Related posts
Tags: children, focalin, patients, reported, treatment
Posted in New drug approbation | No Comments »
Saturday, November 8th, 2008
Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the support of diminution of ulcerative colitis (UC) in adults. LoSeasonique is a lower-dose, extended-cycle vocal contraceptive indicated for the stopping of pregnancy. Acanya (benzoyl peroxide and clindamycin phosphate) is a timely antibacterial and Antibiotic mix for the remedying of acne. Toviaz (fesoterodine fumarate) is a competitive muscarinic receptor enemy indicated for the healing of overactive bladder with symptoms of desire urinary incontinence, urgency, and frequency.
Vimpat (lacosamide) is an anti-convulsant cure for the therapy of incomplete outset seizures in adults with epilepsy. Astepro (azelastine) is a nasal antihistamine for the curing of seasonal allergic rhinitis. Rapaflo (silodosin) is an alpha(1)- adrenoreceptor opposition for the Care of the signs and symptoms associated with warm prostatic hyperplasia (BPH), or enlarged prostate.
(more...)
Related posts
Tags: acting, adults, associated, indicated, patients, treatment
Posted in Alerts about drugs | No Comments »
Friday, October 31st, 2008
The children, recruited from six regionally dispersed sites throughout the United States, All had commonsensical to dire splitting uneasiness disorder, generalized apprehension melee or popular phobia. Many also had coexisting disorders, including Other nervousness disorders, concentration shortage hyperactivity disorder, and behavior problems. John Walkup, M.D., of Johns Hopkins Medical Institutions, and colleagues found that amongst those in conjunction treatment, 81 percent improved.
Sixty percent in the CBT-only coterie improved, and 55 percent in the sertraline-only unit improved. Among those on placebo, 24 percent improved. A jiffy slant of the haunt will invigilator the children for an additional six months. "CAMS definitely showed that league healing is the most functioning for these children. But sertraline peerless or CBT alone showed a acceptable response rate as well.
(more...)
Related posts
Tags: children, disorders, improved, percent, sertraline, treatment, university
Posted in Hospital trials | No Comments »
Thursday, October 30th, 2008
TRU-015 Phase 1/2a Re-treatment Data: Re-treatment Administered Every 24 Weeks for 2 Years Produces Well-Tolerated and Consistent Results Re-treatment information from the Phase 1/2a chew over (15001) were presented on Oct. 26, 2008, in a announcement hearing at the ACR 2008 Annual Meeting in San Francisco. Patients treated with a only movement of TRU-015 at 5 mg/kg or higher in a beforehand conducted Phase 1/2a office (15001) were available for re-treatment.
Patients given an opening prescribe of 5 mg/kg received a distinct infusion of 5 mg/kg upon re-treatment and those given higher doses of TRU-015 received a free infusion of 15 mg/kg upon re-treatment. Patients were unwed for reproduction remedial programme at 24-week intervals. Thirty-eight patients entered the Phase 1/2a re-treatment study; some patients have received as many as seven courses of TRU-015 at the era of this assessment. At 24 weeks, ACR 20, 50 and 70 reaction rates for 18 patients that have received their third re-treatment with 5 mg/kg or 15 mg/kg TRU-015 were 50%, 17% and 11%, respectively.
(more...)
Related posts
Tags: patients, phase, received, results, treatment, trubion
Posted in Hospital trials | No Comments »
Saturday, October 11th, 2008
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that command a local anesthetic agent. AdreView is a diagnostic radiopharmaceutical agency indicated for use in the detection of underdone neuroendocrine tumors in children and adults. Sancuso (granisetron transdermal system) is an anti-emetic transdermal presentation set indicated for the guidance of nausea and vomiting in patients receiving in moderation and/or influentially nausea-inducing chemotherapy.
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the curing of thrombocytopenia in matured patients with hardened inoculated (idiopathic) thrombocytopenic purpura (ITP). Xenazine (tetrabenazine) is a discerning and reversible centrally-acting dopamine depleting soporific indicated for the remedying of chorea associated with Huntington's disease. Cleviprex is an intravenous, ultrashort-acting calcium course blocker under progress for the healing of forbiddingly eminent Blood pressing in the nursing home environs when vocal therapy is not doable or desirable. Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric kind gelatin capsule transport organized whole designed to minimize GI adverse events.
(more...)
Related posts
Tags: diphtheria, indicated, ocular, ophthalmic, treatment
Posted in Alerts about drugs | No Comments »
Friday, September 26th, 2008
LONDON, Sept. 22, 2008-The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (24 September 2008) published a guideline on the diagnosis and directing of concentration shortfall hyperactivity affliction (ADHD) in children, progeny bodies and adults. ADHD is a unexceptional behavioural complaint in children and callow populace estimated to strike up to 3% of school-age children and junior population in the UK, and about 2% of adults worldwide. It commonly starts in ancient boyhood and some commonality will resume to have ADHD as adults.
Severe ADHD is occasionally known as ‘hyperkinetic disorder’. The symptoms of ADHD include: being unconcerned (unable to think for very great or cease a task); hyperactivity (fidgety and unfit to sit still); and impulsive (speaking without point of view about the consequences). It is an darned distressing disorder, affecting the being as well as their families and carers.
(more...)
Related posts
Tags: children, offered, training, treatment
Posted in News | No Comments »
Wednesday, September 17th, 2008
These results, from the RADIANT-1 (RAD001 In Advanced Neuroendocrine Tumors) study, were presented today at the 33rd European Society for Medical Oncology (ESMO) Congress in Stockholm, Sweden. In the Trial, patients with pancreatic NET who became rebellious to chemotherapy were given either ordinary RAD001 combined with monthly Sandostatin LAR Depot or every day RAD001 alone. The results showed that 82% of patients receiving society remedy and 77% receiving monotherapy had tumors that either decreased in Weight or remained stable. "Pancreatic neuroendocrine tumors cause debilitating symptoms tied up to hormone building and typically contend the lives of patients within five years regard for curing with chemotherapy, which is the prevalent emblem of Care," said James Yao, MD, Associate Professor of Medicine at The M. D. Anderson Cancer Center.
"Results from this examination show the likelihood of RAD001, with or without Sandostatin LAR Depot, to equip tumor shrinkage or resolve and to widen stretch without contagion headway in patients who currently have little therapy options." The cramming explores the developing of mTOR impediment for patients with pancreatic NET by examining RAD001 solitary or in league with regulative of trouble treatment, Sandostatin LAR Depot. RAD001 is a once-daily vocalized psychoanalysis that continuously inhibits the mTOR protein, a middle regulator of cubicle class and tumor Blood also bark Growth. "These findings begin to entrench the impersonation of RAD001 as a cheering changed alternative for patients with a special and deadly form of Cancer that historically has not responded well to any treatment," said David Epstein, President and CEO of Novartis Oncology. "The coalition of RAD001 and Sandostatin LAR Depot may present a narrative Care manner for sickness and symptom control in patients with pancreatic neuroendocrine tumors who are unmanageable to chemotherapy.
(more...)
Related posts
Tags: depot, patients, rad001, results, sandostatin, treatment, tumors
Posted in Hospital trials | No Comments »
Thursday, September 4th, 2008
Introgen has requested Priority Review from the FDA for Advexin. Priority Review is typically granted to compounds that contribute significant medical profit compared to existing treatments for a disease. If Priority Review is granted, the FDA will have up to six months from docility time to attract fight on the dossier. Advexin is considered an 'Orphan Drug' in the US for the healing of recurrent, refractory make a beeline for and neck Cancer, which, if approved, entitles the benumb to extended customer base exclusivity for the approved indication.
"This is an conspicuous milestone in the clinical attentiveness stick-to-it-iveness of gene group therapy for Cancer patients," said Jack A. Roth, MD, inventor of Advexin and Professor and Bud Johnson Clinical Distinguished Chair, Department of Thoracic and Cardiovascular Surgery, at M.D. Anderson Cancer Center.
(more...)
Related posts
Tags: advexin, cancer, clinical, introgen, patients, treatment, tumor
Posted in New drug use and attentions | No Comments »
Thursday, August 21st, 2008
Today, there's a reborn remedying privilege for the millions of adults in the United States with ADHD: Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) announced the U.S. Food and Drug Administration (FDA) approved J&JPRD's Supplemental New Drug Application (sNDA) for Concerta curing of ADHD in adults ages 18 to 65.
The doses approved for adults across from 18 to 72 mg daily. Today's approbation expands the Concerta warning from children and adolescents into adults with ADHD, and offers these patients a patented once- day after day formulation. Using its lone OROS confinement system, the Concerta formulation delivers an endorse quantity of medication when the slab is ingested.
(more...)
Related posts
Tags: adolescents, adults, children, concerta, mcneil, pediatrics, treatment
Posted in New drug approbation | No Comments »
Wednesday, March 19th, 2008
Intelence (etravirine) is a non-nucleoside revoke transcriptase inhibitor (NNRTI) which in coalition with Other antiretroviral agents is indicated for the remedying of kind immunodeficiency virus typeface 1 (HIV-1) infection in antiretroviral treatment-experienced grown patients. Tekturna HCT (aliskiren and hydrochlorothiazide) is a single-tablet federation remedial programme for the Care of on a trip Blood Pressure. Flo-Pred (prednisolone acetate) is a cherry flavored said fluid corticosteroid formulation which does not desire refrigeration and does not call shaking ex to use. Flo-Pred is an anti-inflammatory force for the treatment of Asthma, definite allergic and dermatologic conditions, as well as a class of Other indications.
Alvesco (ciclesonide) is an inhaled corticosteroid indicated for the allowance therapy of Asthma and as prophylactic therapy in mature and adolescent patients aged 12 years and older. Recothrom is a recombinant put up of kindly thrombin is indicated as an uphold to hemostasis whenever oozing Blood and laddie bleeding from capillaries and mignon venules is accessible and handle of bleeding by standard surgical techniques is bootless or impractical. Recothrom may be occupied in conjunction with an absorbable gelatin sponge, USP.
(more...)
Related posts
Tags: conjunction, corticosteroid, indicated, kuvan, phenylalanine, treatment
Posted in Alerts about drugs | No Comments »
